Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CCMI

Copy Product Info
😃Good
Catalog No. T7422Cas No. 917837-54-8
Alias AVL-3288

CCMI (AVL-3288) is a potent and selective modulator of α7 nAChR-positive allosteric sites.

CCMI

CCMI

Copy Product Info
😃Good
Catalog No. T7422Alias AVL-3288Cas No. 917837-54-8
CCMI (AVL-3288) is a potent and selective modulator of α7 nAChR-positive allosteric sites.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$33In StockIn Stock
5 mg$48In StockIn Stock
10 mg$81In StockIn Stock
25 mg$137In StockIn Stock
50 mg$196-In Stock
1 mL x 10 mM (in DMSO)$54In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CCMI AI Summary
CCMI exhibits significant bioactivity as a positive allosteric modulator of human alpha-7 nicotinic acetylcholine receptors (nAChR) expressed in Xenopus oocytes. It enhances the response to acetylcholine (ACh), choline, and nicotine by modulating the induced currents with various EC50 values. The compound also affects GABAA alpha-2-beta-3-gamma-2L receptors and demonstrates differing EC50 values for GABA-induced current modulation. Notably, CCMI displaces [125I]alpha-bungarotoxin from alpha-7 nAChR in rat brain regions, exhibiting distinct IC50 and Ki values. Additionally, it exhibits activity in SH-SY5Y cells and shows measurable drug uptake in DBA/2 mouse brains following intravenous and oral administration. Specifically, at 0.3 mg/kg intravenously, the uptake is 1.0 µM after 10 minutes and 0.3 µM after 90 minutes; when administered orally to NSA mice, the uptake is 0.15 µM after 120 to 150 minutes..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CCMI (AVL-3288) is a potent and selective modulator of α7 nAChR-positive allosteric sites.
SynonymsAVL-3288
Chemical Properties
Molecular Weight388.25
FormulaC19H15Cl2N3O2
Cas No.917837-54-8
SmilesCc1cc(on1)C(=C/Nc1ccc(Cl)cc1)\C(=O)Nc1ccc(Cl)cc1
Relative Density.1.412 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (257.57 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (10.3 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5757 mL12.8783 mL25.7566 mL128.7830 mL
5 mM0.5151 mL2.5757 mL5.1513 mL25.7566 mL
10 mM0.2576 mL1.2878 mL2.5757 mL12.8783 mL
20 mM0.1288 mL0.6439 mL1.2878 mL6.4392 mL
50 mM0.0515 mL0.2576 mL0.5151 mL2.5757 mL
100 mM0.0258 mL0.1288 mL0.2576 mL1.2878 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CCMI | purchase CCMI | CCMI cost | order CCMI | CCMI chemical structure | CCMI formula | CCMI molecular weight